Skip to content
Screener

Geron GERN Net margin

Net margin at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
18.9%+8.4pp
Incyte logo
IncyteINCY
27.7%+8.7pp
Immunome logo
ImmunomeIMNM
-5,593.8%-11,284pp
Exelixis logo
ExelixisEXEL
35.3%+8.3pp
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-8.9%-20.5pp
Gilead Sciences logo
Gilead SciencesGILD
-10.6%-32.5pp

Other financials

Income statement

See full
Revenue$57.5M+17.2%
Operating income-$12.5M-0.3%
Net income-$16.7M-1.9%
EPS (diluted)-$0.020.0%

Balance sheet

See full
Cash & equivalents$64.5M-18.9%
Total debt$134.1M-0.3%
Total equity$218.6M-15.8%
Total assets$519.0M-6.5%

Cash flow

See full
Operating cash flow-$15.8M+42.3%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$1.01B+13.8%
Enterprise value$1.08B+14.5%
P/S4.9×-180×

Profitability

See full
Operating margin-705.5%-351pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-28.3%-2.3pp
Debt / equity0.6×+0.1×
Current ratio6.9×-1.0×

Where this comes from

Calculated from Geron’s reported figures.

Based on trailing twelve months.

The source filing: Geron’s 10-Q, filed November 7, 2024. Open the filing →

Filed
Nov 7, 2024
Fiscal quarter
Q3 FY2024
Calendar quarter
Q3 2024
Accession
0000950170-24-123282

FAQ

What is Geron's net margin?
Geron (GERN) reported net margin of -682.5% in Q3 2024.
How has Geron's net margin changed year-over-year?
Geron's net margin increased by 98.8% year-over-year, from -55,138.5% to -682.5%.
What is the long-term trend for Geron's net margin?
Over 3 years (2020 to 2023), Geron's net margin has grown at a 37.5% compound annual growth rate (CAGR), from -29,888.1% to -77,690.7%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Ask your AI about Geron's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude